Delivered by OHMG Ltd., this 9,000m2 facility was established to deepen our understanding of disease mechanisms and enhance patient outcomes. It accommodates 330 staff members specializing in research, with a focus on finding cures for eye diseases and diabetes, and contributing to a global program unraveling the genetics of chronic diseases.

A notable feature of the building is its twin-skin exterior envelope, strategically designed to improve thermal performance. At the heart of the Institute is a central atrium, serving as a focal point for meetings, displays, and conferences, fostering collaboration and interaction among researchers.

This facility, which has since become a multi-award-winning project, received an excellent BREEAM rating for its environmental sustainability. It stands as a testament to OHMG Ltd.’s commitment to creating a more sustainable and eco-friendly research facility, recognized for its outstanding contributions in the field.